<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03848728</url>
  </required_header>
  <id_info>
    <org_study_id>SEARCH Youth</org_study_id>
    <secondary_id>UG3HD096915-01</secondary_id>
    <nct_id>NCT03848728</nct_id>
  </id_info>
  <brief_title>Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa</brief_title>
  <official_title>Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Infectious Diseases Research Collaboration, Uganda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kenya Medical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate the effect of a combination intervention on long-term
      HIV viral load (VL) suppression among HIV-infected adolescents and young adults 15-24 years
      of age. The study will take place in 28 rural HIV clinics in western Kenya and southwest
      Uganda. Clinics will be randomly chosen to either continue to provide study participants
      standard care or to provide the study intervention, which consists of discussion and
      counseling on major issues or life events, flexible access to the clinic, and rapid
      turnaround of VL test results. Participants will take part in the study for at least 2 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The randomized controlled trial (RCT) will evaluate the effect of the SEARCH Youth
      intervention on long-term HIV viral load suppression among HIV-infected adolescents/young
      adults. The study's intervention is based on the PRECEDE model of behavioral change that is
      targeted towards adolescent and young adult behavior. The study design is a
      cluster-randomized trial where the unit of randomization is the HIV clinic: 14 clinics
      randomized to the intervention and 14 to the optimized country standard of care
      (Differentiated ART care, standard clinic hours, routine VL monitoring, access to 2nd and 3rd
      line ART), balanced within country. The target enrollment for the intervention is
      approximately 1400 (50 adolescents/young adults with HIV in each clinic).

      Community-tailored youth testing and linkage strategies for ART will be implemented to
      recruit youth for the SEARCH Youth combination intervention RCT. Strategies to reach youth at
      the highest risk of HIV infection will be implemented. Those individuals who test
      HIV-positive will be referred to the local clinic for HIV treatment services and, if they
      otherwise meet entry criteria, to the SEARCH Youth study for possible inclusion.

      The components of the SEARCH Youth intervention include:

        -  Administration of life-stage assessment tool at the beginning of each visit that links
           to life-stage specific actions and puts subsequent medical discussions into an
           appropriate context

        -  Structured choice clinic access which will provide a choice to schedule visits during or
           after routine clinic hours or in an alternate location, with some phone-only visits
           available between in-person visits

        -  Rapid feedback of VL results, by phone or in person, aiming to be provided within 72
           hours, to provide immediate feedback on HIV suppression and engage participants in their
           overall health

        -  Provider e-collaboratives that comprises of chat groups using WhatsApp or similar secure
           messaging applications to solicit input about challenging cases using de-identified
           information

      Participants will take part in the study for at least 2 years.

      Some participants, family members, providers and key informants will also take part in
      qualitative interview guides. Costs of the SEARCH Youth intervention will be evaluated to
      assess its efficiency and cost-effectiveness including as cost per participant, cost per
      additional participant with viral suppression and cost per DALY gained.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2019</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cluster-randomized trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of SEARCH Youth intervention</measure>
    <time_frame>2 years</time_frame>
    <description>Proportion of study participants with virologic suppression (HIV RNA &lt;400 c/mL) at 2 years of follow-up</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1450</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Intervention Clinics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SEARCH Youth combination intervention, which includes life-stage assessment and counseling, rapid VL feedback, structured choice clinic access, and e-collaboratives chat-based discussion among providers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Clinics</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Optimized country standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SEARCH Youth combination intervention</intervention_name>
    <description>Administration of life-stage assessment tool
Structured choice clinic access
Rapid feedback of VL results
Provider e-collaboratives with chat groups for discussions of challenging cases using de-identified information</description>
    <arm_group_label>Intervention Clinics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infection diagnosed according to country testing guidelines

          -  Age 15-24 years

          -  Enrolled in care in a study clinic

          -  Ability and willingness to provide informed consent

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diane V Havlir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moses R Kamya, MBChB, MMed, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Makerere University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane V Havlir, MD</last_name>
    <phone>415-476-4082</phone>
    <phone_ext>400</phone_ext>
    <email>diane.havlir@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Moses R Kamya, MBChB, MMed, PhD</last_name>
    <phone>+256-312-281479</phone>
    <email>mkamya@idrc-uganda.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Western Kenya</name>
      <address>
        <city>Sindo</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Bukusi, MBChB, M.Med, MPH, PhD</last_name>
      <phone>+254-733-617503</phone>
      <email>ebukusi@rctp.or.ke</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Bukusi, MBChB, M.Med, MPH, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwestern Uganda</name>
      <address>
        <city>Mbarara</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moses R Kamya, MBChB, MMed, PhD</last_name>
      <phone>+256-312-281479</phone>
      <email>mkamya@idrc-uganda.org</email>
    </contact>
    <investigator>
      <last_name>Moses R Kamya, MBChB, MMed, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Kenya</country>
    <country>Uganda</country>
  </location_countries>
  <reference>
    <citation>Lamb MR, Fayorsey R, Nuwagaba-Biribonwoha H, Viola V, Mutabazi V, Alwar T, Casalini C, Elul B. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care. AIDS. 2014 Feb 20;28(4):559-68. doi: 10.1097/QAD.0000000000000054.</citation>
    <PMID>24076661</PMID>
  </reference>
  <reference>
    <citation>Evans D, Menezes C, Mahomed K, Macdonald P, Untiedt S, Levin L, Jaffray I, Bhana N, Firnhaber C, Maskew M. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses. 2013 Jun;29(6):892-900. doi: 10.1089/AID.2012.0215. Epub 2013 Feb 25.</citation>
    <PMID>23373540</PMID>
  </reference>
  <reference>
    <citation>Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71. doi: 10.1097/QAI.0b013e318199072e.</citation>
    <PMID>19282780</PMID>
  </reference>
  <reference>
    <citation>Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, Khogali M, Lujan J, Antierens A, Teck R, Ellman T, Kosgei R, Reid T. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015 Feb 19;10(2):e0116144. doi: 10.1371/journal.pone.0116144. eCollection 2015.</citation>
    <PMID>25695494</PMID>
  </reference>
  <reference>
    <citation>ZÃ¼rcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, Egger M; IeDEA and MESH consortia. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health. 2017 Apr;22(4):375-387. doi: 10.1111/tmi.12843. Epub 2017 Feb 20. Review.</citation>
    <PMID>28102610</PMID>
  </reference>
  <reference>
    <citation>Massaquoi M, Zachariah R, Manzi M, Pasulani O, Misindi D, Mwagomba B, Bauernfeind A, Harries AD. Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg. 2009 Jun;103(6):594-600. doi: 10.1016/j.trstmh.2009.02.012. Epub 2009 Mar 18.</citation>
    <PMID>19298993</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>May 22, 2020</last_update_submitted>
  <last_update_submitted_qc>May 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Adolescent</keyword>
  <keyword>Young Adult</keyword>
  <keyword>Viral Load</keyword>
  <keyword>Counseling</keyword>
  <keyword>Costs and Cost Analysis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

